Teva's Innovative Portfolio Fuels 10th Consecutive Quarter of Growth in Q2 2025; Increases 2025 Revenue Outlook for Key Innovative Products and EPS, and Reaffirms All Other Components

Go back to Teva's Innovative Portfolio Fuels 10th Consecutive Quarter of Growth in Q2 2025; Increases 2025 Revenue Outlook for Key Innovative Products and EPS, and Reaffirms All Other Components
TEVA PHARMACEUTICAL INDUSTRIES (NYSE: TEVA) Delayed: 36.85 +0.09 (0.24%)
Previous Close $36.76    52 Week High $66.55 
Open $36.82    52 Week Low $37.82 
Day High $37.32    P/E N/A 
Day Low $36.47    EPS $0.00 
Volume 3,999,706       

TEVA PHARMACEUTICAL INDUSTRIES (NYSE: TEVA) Delayed: 36.85 +0.09 (0.24%)
Previous Close $36.76    52 Week High $66.55 
Open $36.82    52 Week Low $37.82 
Day High $37.32    P/E N/A 
Day Low $36.47    EPS $0.00 
Volume 3,999,706